Back to results
US 2015/0306113 A1Published application
Bismuth Containing Liquid Pharmaceutical Suspensions
AssigneeThe Procter & Gamble Company
InventorsDaniel Jerome White, Jr., Michael Selden Godlewski, Timothy Charles Gulbin, Graham John Myatt
Life of this patent
Estimating the term…
Abstract
A liquid pharmaceutical suspension for oral administration containing a bismuth-containing pharmaceutical agent, a suspension system, and water. The suspension system can contain from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate.
Claims19
A liquid pharmaceutical suspension for oral administration comprising:
- a. a bismuth-containing pharmaceutical agent;
- b. a suspension system comprising from about 0.001% to about 0.2% gellan gum and from about 0.001% to about 0.75% magnesium aluminum silicate;
- c. water.
A liquid pharmaceutical suspension for oral administration comprising:
- a. a bismuth-containing pharmaceutical agent;
- b. a suspension system comprising gellan gum;
- c. water.
A liquid pharmaceutical suspension for oral administration comprising:
- a. a bismuth-containing pharmaceutical agent;
- b. a suspension system;
- c. water;
- wherein the formulation comprises less than about 0.2 ppm lead and wherein the liquid formulation has no more than slight sedimentation is visually perceptible after 30 days at 40° C.
1 more element
Dependencies are inferred from the claim text.